At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II Study of Hypofractionated Pre-Operative Radiation Therapy for Localized, Resectable Soft Tissue Sarcoma of the Extremity and Superficial Trunk
In Brief
A Phase 2 clinical trial evaluating Hypofractionated Radiation Therapy, Quality-of-Life Assessment, and 2 other interventions for Resectable Soft Tissue Sarcoma and 4 related conditions. Active but no longer recruiting, targeting 120 participants across 3 sites.
Detailed Summary
This phase II trial investigates the effects of hypofractionated radiation therapy before surgery on wound complications associated with surgery in treating patients with soft tissue sarcoma of the extremity (arms, hands, legs or feet) and superficial trunk that has not spread to other parts of the body (localized) and can be removed by surgery (resectable). Hypofractionated is a shorter radiation therapy treatment length (fewer radiation treatment days) and administers the total radiation dose as larger daily doses, compared to conventionally fractionated therapy.
Study Details
Timeline
Interventions
Undergo hypofractionated radiation therapy
Ancillary studies
Ancillary studies
Undergo surgical resection